Adding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in ...

Recently, the world’s first FlowRay Photon Skin-Rejuvenation Device‌, co-developed by the Massachusetts Institute of ...

A new study published in The Journal of Dermatological Treatment showed that for vitiligo patients, phototherapy combined with topical antioxidants, corticosteroids, or calcineurin inhibitors ...

The combination of a targeted oral medication with light therapy may enhance repigmentation for patients living with nonsegmental vitiligo, a team of ...

Compared to traditional beauty devices, the FlowRay Photon Skin-Rejuvenation Device introduces three groundbreaking ...

Two new studies suggest optical computing, which uses light to process data, is much closer to becoming a faster, more energy-efficient alternative to conventional systems. One study used an ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. A new documentary ...

Narrowband UVB (nbUVB) phototherapy is not being fully utilized in treating pediatric vitiligo, as highlighted by a recent study published in the journal Pediatric Dermatology. Researchers conducted ...

A new network meta-analysis compares combined phototherapy and topical treatments for vitiligo, revealing antioxidants, corticosteroids, and calcineurin inhibitors as top-performing partners.

Brenner's initial main target has been seasonal flu, but that could change. "UV light really doesn't care about the details of whether it's a bacteria or a virus. It can kill all of them ...

TUESDAY, April 8, 2025 (HealthDay News) — Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March 18 in Pediatric Dermatology.